Select or drop a image or 3D model here to search.
We support JPG, JPEG, PNG, GIF, WEBP, GLB, OBJ, STL, FBX. More formats will be added in the future.
Asset Overview
Gefitinib is an anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04)
Download from NIH 3D Print Exchange: http://3dprint.nih.gov/discover/3dpx-003112
